Cargando…

Distinct microRNA Expression Profile in Prostate Cancer Patients with Early Clinical Failure and the Impact of let-7 as Prognostic Marker in High-Risk Prostate Cancer

BACKGROUND: The identification of additional prognostic markers to improve risk stratification and to avoid overtreatment is one of the most urgent clinical needs in prostate cancer (PCa). MicroRNAs, being important regulators of gene expression, are promising biomarkers in various cancer entities,...

Descripción completa

Detalles Bibliográficos
Autores principales:	Schubert, Maria, Spahn, Martin, Kneitz, Susanne, Scholz, Claus Jürgen, Joniau, Steven, Stroebel, Philipp, Riedmiller, Hubertus, Kneitz, Burkhard
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2013
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3683014/ https://www.ncbi.nlm.nih.gov/pubmed/23798998 http://dx.doi.org/10.1371/journal.pone.0065064

Ejemplares similares

MiR-205 Is Progressively Down-Regulated in Lymph Node Metastasis but Fails as a Prognostic Biomarker in High-Risk Prostate Cancer
por: Kalogirou, Charis, et al.
Publicado: (2013)

Combination of expression levels of miR-21 and miR-126 is associated with cancer-specific survival in clear-cell renal cell carcinoma
por: Vergho, Daniel, et al.
Publicado: (2014)

The Role of Adjuvant Hormonal Treatment after Surgery for Localized High-Risk Prostate Cancer: Results of a Matched Multiinstitutional Analysis
por: Schubert, Maria, et al.
Publicado: (2012)

Relaxed imprinting of IGF2 in peripheral blood cells of patients with a history of prostate cancer
por: Belharazem, Djeda, et al.
Publicado: (2012)

Impact of miR-21, miR-126 and miR-221 as Prognostic Factors of Clear Cell Renal Cell Carcinoma with Tumor Thrombus of the Inferior Vena Cava
por: Vergho, Daniel Claudius, et al.
Publicado: (2014)

miR-221-5p regulates proliferation and migration in human prostate cancer cells and reduces tumor growth in vivo
por: Kiener, Mirjam, et al.
Publicado: (2019)

DNA Methylation-Guided Prediction of Clinical Failure in High-Risk Prostate Cancer
por: Litovkin, Kirill, et al.
Publicado: (2015)

High expression of Sterol-O-Acyl transferase 1 (SOAT1), an enzyme involved in cholesterol metabolism, is associated with earlier biochemical recurrence in high risk prostate cancer
por: Eckhardt, Carolin, et al.
Publicado: (2021)

miR-221-3p Regulates VEGFR2 Expression in High-Risk Prostate Cancer and Represents an Escape Mechanism from Sunitinib In Vitro
por: Krebs, Markus, et al.
Publicado: (2020)

miR-221 Augments TRAIL-Mediated Apoptosis in Prostate Cancer Cells by Inducing Endogenous TRAIL Expression and Targeting the Functional Repressors SOCS3 and PIK3R1
por: Krebs, Markus, et al.
Publicado: (2019)

Loss of tumor suppressor mir-203 mediates overexpression of LIM and SH3 Protein 1 (LASP1) in high-risk prostate cancer thereby increasing cell proliferation and migration
por: Hailer, Amelie, et al.
Publicado: (2014)

What is the Need for Prostatic Biomarkers in Prostate Cancer Management?
por: Spahn, Martin, et al.
Publicado: (2015)

An Anti-Ubiquitin Antibody Response in Transitional Cell Carcinoma of the Urinary Bladder
por: Ardelt, Peter U., et al.
Publicado: (2015)

MicroRNA let-7c Is Downregulated in Prostate Cancer and Suppresses Prostate Cancer Growth
por: Nadiminty, Nagalakshmi, et al.
Publicado: (2012)

Preoperative Risk-Stratification of High-Risk Prostate Cancer: A Multicenter Analysis
por: Chys, Brecht, et al.
Publicado: (2020)

Salvage Nodal Radiotherapy as Metastasis-Directed Therapy for Oligorecurrent Prostate Cancer Detected by Positron Emission Tomography Shows Favorable Outcome in Long-Term Follow-Up
por: Tamihardja, Jörg, et al.
Publicado: (2022)

Sense and Nonsense of an Extended Pelvic Lymph Node Dissection in Prostate Cancer
por: Van Baelen, Anthony, et al.
Publicado: (2012)

Critical Evaluation of a microRNA-Based Risk Classifier Predicting Cancer-Specific Survival in Renal Cell Carcinoma with Tumor Thrombus of the Inferior Vena Cava
por: Kotlyar, Mischa J., et al.
Publicado: (2023)

Ki-67, topoisomerase IIα and miR-221 have a limited prostate cancer risk stratification ability on a medium-term follow-up: results of a high-risk radical prostatectomy cohort
por: Marra, Giancarlo, et al.
Publicado: (2022)

MicroRNA let-7a: a novel therapeutic candidate in prostate cancer
por: Wu, Xiao-Qin, et al.
Publicado: (2014)

Exploring the Potential of MicroRNA Let-7c as a Therapeutic for Prostate Cancer
por: Mulholland, Eoghan J., et al.
Publicado: (2019)

Mdm2-SNP309 polymorphism in prostate cancer: no evidence for association with increased risk or histopathological tumour characteristics
por: Stoehr, R, et al.
Publicado: (2008)

Preclinical Models in Prostate Cancer: Resistance to AR Targeting Therapies in Prostate Cancer
por: Devlies, Wout, et al.
Publicado: (2021)

DNA Methylation Mediated Control of Gene Expression Is Critical for Development of Crown Gall Tumors
por: Gohlke, Jochen, et al.
Publicado: (2013)

Obesity and prostate cancer research
por: Van den Broeck, Thomas, et al.
Publicado: (2013)

Impact of Lymph Node Burden on Survival of High-risk Prostate Cancer Patients Following Radical Prostatectomy and Pelvic Lymph Node Dissection
por: Moris, Lisa, et al.
Publicado: (2016)

Oligometastatic prostate cancer: Metastases-directed therapy?
por: Van Poppel, Hein, et al.
Publicado: (2016)

Tumor thrombus of inferior vena cava in patients with renal cell carcinoma – clinical and oncological outcome of 50 patients after surgery
por: Vergho, Daniel Claudius, et al.
Publicado: (2012)

The Genomic Landscape of Prostate Cancer
por: Spans, Lien, et al.
Publicado: (2013)

PREDICT Prostate, a useful tool in men with low- and intermediate-risk prostate cancer who are hesitant between conservative management and active treatment
por: Devos, Gaëtan, et al.
Publicado: (2020)

Blood Vessel Density in Basal Cell Carcinomas and Benign Trichogenic Tumors as a Marker for Differential Diagnosis in Dermatopathology
por: Winter, Julia, et al.
Publicado: (2011)

The potential of tumour microenvironment markers to stratify the risk of recurrence in prostate cancer patients
por: Gevaert, Thomas, et al.
Publicado: (2020)

Nanoribbon Biosensor-Based Detection of microRNA Markers of Prostate Cancer
por: Ivanov, Yuri D., et al.
Publicado: (2023)

Somatic Hypermutation in Muts Homologue (Msh)3-, Msh6-, and Msh3/Msh6-Deficient Mice Reveals a Role for the Msh2–Msh6 Heterodimer in Modulating the Base Substitution Pattern
por: Wiesendanger, Margrit, et al.
Publicado: (2000)

MicroRNAs in prostate cancer
por: Kim, Won Tae, et al.
Publicado: (2012)

microRNAs and prostate cancer
por: Shi, Xu-Bao, et al.
Publicado: (2008)

Micrornas in prostate cancer: an overview
por: Vanacore, Daniela, et al.
Publicado: (2017)

MicroRNA-22 increases senescence and activates cardiac fibroblasts in the aging heart
por: Jazbutyte, Virginija, et al.
Publicado: (2012)

EGFR as a stable marker of prostate cancer dissemination to bones
por: Nastały, Paulina, et al.
Publicado: (2020)

MiR-205-driven downregulation of cholesterol biosynthesis through SQLE-inhibition identifies therapeutic vulnerability in aggressive prostate cancer
por: Kalogirou, C., et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_6hrnb3e3oq65n7nki841slauql